Revolutionizing the Future of Biologics

Engineering cutting-edge antibody-based therapeutics to tackle cancer and rare diseases through AI-driven innovation.

AntibodyGenX

AI-powered discovery of high-affinity antibodies with precise antigen interaction predictions.

ADCGenX

Optimized workflows for seamless antibody-drug conjugate (ADC) development.

HumanReplica

Advanced human-mimicking platforms for accurate preclinical validation.

The Convergence of AI & Biologics

To engineer and develop cutting-edge antibodies, payloads, and Antibody Drug-Conjugates (ADCs) that address the most challenging medical conditions. We collaborate with pharmaceutical partners to provide seamless solutions from concept to validation.

 

Our Vision

To redefine biologics drug discovery by leveraging AI-powered platforms, making innovative therapies more efficient and accessible.

Our Mission

Advancing the future of medicine by integrating AI into antibody engineering, ADC development, and preclinical modeling to deliver groundbreaking solutions.

Transforming Drug Discovery with AI

  • Tech-Driven Antibody Engineering
    Leveraging AI for rapid antibody screening and therapeutic optimization.

  • Seamless Preclinical Integration
    Bridging computational drug discovery with real-world clinical applications.

Unlocking the full potential of AI-powered biologics.

  • Smart Solutions – AI-tailored platforms for accelerated drug development.

  • Certified Expertise – A multidisciplinary team of AI specialists, bioengineers, and pharmaceutical scientists.

Our Services

Introducing Our Fully-Integrated Drug Discovery Suite

PayloadGenX

AI-based filtering of chemical databases like ZINC12, ChEMBL, and PubChem.
--------------------------------------------
Selection of anticancer-like small molecules through molecular docking.
--------------------------------------------
Intelligent payload optimization for targeted ADC efficacy.

LinkerGenX

AI-powered augmentation and validation of linker designs.
--------------------------------------------
BART-model training for precise conjugate-linker-payload relationships.
--------------------------------------------
Advanced linker property analysis, including LogP, MW, and PSA.

Accelerating Biologics Discovery with AI

At Biologics4U, we harness the power of AI to revolutionize antibody-based therapeutics, making drug discovery faster, smarter, and more precise. Join us in shaping the future of medicine.